Dr Hamoun Rozati is a Consultant Clinical Oncologist specialising in radiotherapy, stereotactic radiosurgery, and systemic cancer therapies. He is Clinical Lead for Stereotactic Radiosurgery and Head of Training at a leading London cancer centre, and was ranked first nationally in Clinical Oncology training in the UK.
His practice spans uro-oncology and neuro-oncology, including prostate, bladder, renal and brain tumours, with advanced experience in Gamma Knife, CyberKnife, LINAC-based radiosurgery and SABR. He is a Principal Investigator in multiple clinical trials and senior author of national radiotherapy guidelines, with contributions to leading journals and textbooks, including Kumar & Clark.
Dr Rozati provides CPR-compliant medico-legal reports in clinical negligence and oncology cases, with clear, structured, evidence-based opinions, and is available for court attendance and oral evidence.
Consultant Clinical Oncologist
Barts Cancer Centre, St Bartholomew’s Hospital, London
2023 – Present
Clinical Lead for stereotactic radiosurgery
Specialist in uro-oncology and neuro-oncology
Principal Investigator for oncology clinical trials
Experience
Dr Rozati completed his medical degree at Brighton & Sussex Medical School, followed by MRCP, FRCR (Clin Onc), an MSc in Oncology, and an MD(Res) from Imperial College London. He trained in Clinical Oncology in London (ST3–ST7) and completed a Gamma Knife Radiosurgery Fellowship at the London Gamma Knife Centre before joining Barts Cancer Centre as a Consultant. In 2026, he completed the King's Fund Leadership Course and attended the British Neuro-Oncology Society Annual Scientific Meeting.